Research Topics
| M H PollackSummaryAffiliation: Massachusetts General Hospital Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorderElizabeth A Hoge
Department of Psychiatry, Harvard Medical School, Boston, MA 02114, USA
CNS Spectr 13:522-7. 2008..Individuals with anxiety disorders often remain symptomatic despite treatment with a first-line pharmacologic agent. More research examining pharmacotherapy augmentation strategies to improve outcomes is needed...
A novel cognitive-behavioral approach for treatment-resistant drug dependenceMark H Pollack
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
J Subst Abuse Treat 23:335-42. 2002..Reasons for differential performance by women and men and future directions for this new treatment are discussed...
Comorbidity, neurobiology, and pharmacotherapy of social anxiety disorderM H Pollack
Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston 02114, USA
J Clin Psychiatry 62:24-9. 2001..Efforts to increase the recognition of social anxiety disorder as a common, distressing, and disabling condition are critical. This article discusses the comorbidity, neurobiology, and pharmacotherapy of social anxiety disorder...
Novel treatment approaches for refractory anxiety disordersMark H Pollack
Harvard Medical School and Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Depress Anxiety 25:467-76. 2008..Progress in the development of new treatments has great promise, but will only succeed through a concerted research effort that systematically evaluates potential areas of importance and properly uses scarce resources...
Optimizing pharmacotherapy of generalized anxiety disorder to achieve remissionM H Pollack
Anxiety Disorders Program, Massachusetts General Hospital, Boston 02114, USA
J Clin Psychiatry 62:20-5. 2001..This article discusses the optimization of pharmacotherapy with the goal of promoting remission in patients with GAD...
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorderMark H Pollack
Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Depress Anxiety 24:1-14. 2007..Adverse events were mild or moderate and similar between active treatment groups. Venlafaxine ER and paroxetine were effective and well tolerated in the treatment of panic disorder...
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorderMark H Pollack
Department of Psychiatry, Massachusetts General Hospital, Boston, Mass, USA
J Clin Psychiatry 67:394-9. 2006....
The selective GABA reuptake inhibitor tiagabine for the treatment of generalized anxiety disorder: results of a placebo-controlled studyMark H Pollack
Anxiety Disorders Program, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Simches Research Building, 185 Cambridge Street, Boston, MA 02114, USA
J Clin Psychiatry 66:1401-8. 2005..To evaluate the efficacy and tolerability of tiagabine, a selective gamma-aminobutyric acid (GABA) reuptake inhibitor, in adults with generalized anxiety disorder (GAD)...
Comorbid anxiety and depressionMark H Pollack
Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, Harvard Medical School, Boston, Mass 02114, USA
J Clin Psychiatry 66:22-9. 2005..Cognitive-behavioral therapy is also an effective therapeutic alternative for affected patients...
Olanzapine augmentation of fluoxetine for refractory generalized anxiety disorder: a placebo controlled studyMark H Pollack
Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, USA
Biol Psychiatry 59:211-5. 2006..We present one of the first randomized controlled trials for refractory GAD, comprising double blind augmentation with olanzapine or placebo for patients remaining symptomatic on fluoxetine...
Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorderMark H Pollack
Anxiety Disorders Program, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, WAC 812, 15 Parkman Street, Boston, MA 02114, USA
J Psychiatr Res 36:229-36. 2002....
The pharmacotherapy of panic disorderMark H Pollack
Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, Harvard Medical School, Boston, Mass, USA
J Clin Psychiatry 66:23-7. 2005....
Unmet needs in the treatment of anxiety disordersMark H Pollack
Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, Boston, MA, 02114
Psychopharmacol Bull 38:31-7. 2004..However, a definitive place for these newer therapeutic strategies in the anxiety disorder treatment armamentarium awaits evidence from large, controlled studies. Psychopharmacology Bulletin. 2004;38(Suppl 1): 31-37...
Predictors of outcome following venlafaxine extended-release treatment of DSM-IV generalized anxiety disorder: a pooled analysis of short- and long-term studiesMark H Pollack
Department of Psychiatry, Anxiety Disorders Program, Massachusetts General Hospital, WAC 812, 15 Parkman Street, Boston, MA 02215, USA
J Clin Psychopharmacol 23:250-9. 2003..The strongest trends emerged for history of substance abuse or dependence and symptoms of restlessness, sleep disturbance, and difficulty concentrating...
WCA recommendations for the long-term treatment of panic disorderMark H Pollack
Division of Psychiatry, Huddinge University Hospital, Stockholm, Sweden
CNS Spectr 8:17-30. 2003..Long-term efficacy and ease of use are important considerations in treatment selection, as maintenance treatment is recommended for at least 12-24 months, and in some cases, indefinitely...
Combined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorderMark H Pollack
Department of Psychiatry, Massachusetts General Hospital, and Harvard Medical School, Boston, MA 02114, USA
J Psychopharmacol 17:276-82. 2003..Initiating combined treatment followed by benzodiazepine taper after a few weeks may provide early benefit while avoiding the potential adverse consequences of long-term combination therapy...
Paroxetine in the treatment of generalized anxiety disorder: results of a placebo-controlled, flexible-dosage trialM H Pollack
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
J Clin Psychiatry 62:350-7. 2001..The objective of this randomized, double-blind, placebo-controlled study was to investigate the efficacy and safety of paroxetine in outpatients with generalized anxiety disorder (GAD)...
Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trialMark H Pollack
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, One Bowdoin Square, Sixth Floor, Boston, MA 02114, USA
J Clin Psychiatry 72:892-7. 2011..We present the first prospective, randomized, double-blind, placebo-controlled trial of a non-benzodiazepine hypnotic agent for the treatment of PTSD and associated insomnia...
Refractory generalized anxiety disorderMark H Pollack
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
J Clin Psychiatry 70:32-8. 2009..Innovative treatments, including anticonvulsants, atypical antipsychotics, and others, as well as treatment targeting concomitant insomnia, may help improve outcomes for affected individuals...
Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studiesMark H Pollack
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA
J Clin Psychopharmacol 28:308-16. 2008..018; study 3, P = 0.036). The most common adverse events were dizziness, headache, nausea, fatigue, and somnolence. In conclusion, the results of these studies do not support the efficacy of tiagabine in adult patients with GAD...
Sertraline in the treatment of panic disorder: a flexible-dose multicenter trialM H Pollack
Anxiety Disorders Program, Department of Psychiatry, Massachusetts General Hospital, Boston 02114 3117, USA
Arch Gen Psychiatry 55:1010-6. 1998..We examined the efficacy and safety of the serotonin selective reuptake inhibitor sertraline hydrochloride in patients with panic disorder...
Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorderMark Pollack
Massachusetts General Hospital, Simches Research Bldg, 185 Cambridge St, Ste 2200, 2nd Floor, Boston, MA 02114, USA
Arch Gen Psychiatry 65:551-62. 2008..Insomnia and generalized anxiety disorder (GAD) are prevalent disorders that may coexist...
Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpointMark H Pollack
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Harvard Medical School, Simches Research Building, 185 Cambridge Street, Suite 2200, 2nd Floor, Boston, MA 02114, United States
J Psychiatr Res 42:1176-84. 2008..These data suggest a connection between early improvement and endpoint response and remission status that can be used to guide clinical decision-making...
Social anxiety disorder: designing a pharmacologic treatment strategyM H Pollack
Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, Boston 02114, USA
J Clin Psychiatry 60:20-6. 1999....
Treatment of panic disorder: focus on paroxetineMark H Pollack
Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, Boston, MA 02114, USA
Psychopharmacol Bull 37:53-63. 2003..Continued treatment with paroxetine results in sustained rates of remission compared with placebo. The combination of paroxetine and cognitive behavioral therapy appears to offer benefits of efficacy and sustained therapeutic response...
Panic: course, complications and treatment of panic disorderM H Pollack
Clinical Psychopharmacology Behavior Therapy Unit, Massachusetts General Hospital, Boston 02114, USA
J Psychopharmacol 14:S25-30. 2000..We provide an overview of the prevalence, presentation and associated complications of panic disorder, review the therapeutic options and discuss the management of refractory patients...
A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorderMark Pollack
Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114 2790, USA
Psychopharmacology (Berl) 194:233-42. 2007..Few randomized, placebo-controlled trials have evaluated the comparative efficacy and tolerability of more than one pharmacological agent for panic disorder...
Examining quality of life in patients with generalized anxiety disorder: clinical relevance and response to duloxetine treatmentMark H Pollack
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital Harvard Medical School, Boston, MA 02114, USA
J Psychiatr Res 42:1042-9. 2008..Using comparison norms, the current work describes the clinical relevance of these functional improvements in terms of return to normative functioning and symptom remission...
Sertraline treatment of panic disorder: response in patients at risk for poor outcomeM H Pollack
Department of Psychiatry, Massachusetts General Hospital, Boston 02114 7541, USA
J Clin Psychiatry 61:922-7. 2000..No published research has systematically examined the differential antipanic efficacy of selective serotonin reuptake inhibitors in patients at high risk for poor outcome...
High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetamMark H Pollack
Psychiatry Department, Massachusetts General Hospital, Boston, MA 02114, United States
Prog Neuropsychopharmacol Biol Psychiatry 32:739-43. 2008..Abnormalities in brain gamma-aminobutyric acid (GABA) and glutamate may be relevant to the underlying pathophysiology of anxiety disorders including social anxiety disorder (SAD)...
Panic disorder and response to sertraline: the effect of previous treatment with benzodiazepinesM H Rapaport
Department of Psychiatry, University of California at San Diego, La Jolla, USA
J Clin Psychopharmacol 21:104-7. 2001..Sertraline is both well-tolerated and has significant efficacy in patients with panic disorder, including the subset of patients with panic disorder who have previously been treated with BZs...
Neck-focused panic attacks among Cambodian refugees; a logistic and linear regression analysisDevon E Hinton
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, 15 Parkman Street, WACC 812, Boston, MA 02114, USA
J Anxiety Disord 20:119-38. 2006..In the care of traumatized Cambodian refugees, NP severity, as well as NP-associated flashbacks and catastrophic cognitions, should be specifically assessed and treated...
The anxiety sensitivity index: item analysis and suggestions for refinementM A Blais
Inpatient Psychiatry Service, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA
J Pers Assess 77:272-94. 2001..The 11-item ASI appears to tap 2 primary aspects of anxiety sensitivity: fears of somatic sensations of anxiety and fears of loss of mental control. Suggestions for further development of the ASI are offered...
Assessment of posttraumatic stress disorder in Cambodian refugees using the Clinician-Administered PTSD Scale: psychometric properties and symptom severityDevon E Hinton
Department of Psychiatry, Massachusetts General Hospital, 15 Parkman Street, WACC 812, Boston, MA 02114, USA
J Trauma Stress 19:405-9. 2006..Those patients who met criteria for current PTSD had significantly higher CAPS total scores (M = 65.3, SD = 18.1) than those who did not meet the criteria (M = 13.9, SD = 16.7)...
Group cognitive-behavior therapy for patients failing to respond to pharmacotherapy for panic disorder: a clinical case seriesM W Otto
Massachusetts General Hospital, Boston, USA
Behav Res Ther 37:763-70. 1999....
Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trialMurray B Stein
Department of Psychiatry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093 0985, USA
Psychopharmacology (Berl) 177:280-8. 2005..There is a need for new pharmacological treatments for generalized social anxiety disorder (GSAD), which is a common, often disabling condition...
The panic attack-posttraumatic stress disorder model: applicability to orthostatic panic among Cambodian refugeesDevon E Hinton
Southeast Asian Clinic, Arbour Counseling Services, Lowell, MA 02114, USA
Cogn Behav Ther 37:101-16. 2008....
Prevalence of body dysmorphic disorder in patients with anxiety disordersS Wilhelm
OCD Clinic and Research Unit, Massachusetts General Hospital, Charlestown 02129, USA
J Anxiety Disord 11:499-502. 1997..In all cases, onset of social phobia preceded onset of BDD. Our findings draw attention to the prevalence of BDD in patients with social phobia. The potential etiologic significance of our findings is discussed...
Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled studyM B Stein
Department of Psychiatry, University of California, San Diego, La Jolla 92093 0985, USA
Am J Psychiatry 156:756-60. 1999..The purpose of this study was to determine the efficacy of fluvoxamine for the treatment of social phobia (social anxiety disorder)...
Rate of improvement during cognitive-behavioral group treatment for panic disorderS J Penava
Department of Psychiatry, Massachusetts General Hospital, Boston 02114, USA
Behav Res Ther 36:665-73. 1998..Information on rats of symptom improvement is valuable for providing patients with accurate expectations about potential treatment benefits and for helping to maintain motivation during initial treatment sessions...
Does recovery from substance use disorder matter in patients with bipolar disorder?Roger D Weiss
Department of Psychiatry, Harvard Medical School, Boston, USA
J Clin Psychiatry 66:730-5; quiz 808-9. 2005..To examine the potential impact of recovery from substance use disorder (SUD) on the course of bipolar disorder among patients diagnosed with both bipolar and substance use disorders according to DSM-IV criteria...
History of childhood abuse in panic disorder, social phobia, and generalized anxiety disorderSteven A Safren
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, MGH Psychiatry, WACC 815, 15 Parkman Street, Boston, Massachusetts 02114, USA
J Nerv Ment Dis 190:453-6. 2002..These findings are discussed in terms of biological and behavioral factors that may influence the development of anxiety disorders after the experience of a traumatic event...
A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobiaM W Otto
Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA
J Anxiety Disord 14:345-58. 2000....
Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorderE A Hoge
Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Depress Anxiety 26:447-55. 2009..Much less is known about cytokines in anxiety disorders such as posttraumatic stress disorder (PTSD) and panic disorder (PD). We hypothesized that PD and PTSD would be associated with a generalized proinflammatory cytokine signature...
Childhood history of anxiety disorders among adults with social phobia: rates, correlates, and comparisons with patients with panic disorderM W Otto
Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Depress Anxiety 14:209-13. 2001....
Anxiety is associated with impulsivity in bipolar disorderCharles T Taylor
Department of Psychiatry, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
J Anxiety Disord 22:868-76. 2008..These data demonstrate that anxiety is positively associated with impulsivity in patients with BD. Further studies are needed to elucidate the implications of and reasons for this association...
Benzodiazepines in clinical practice: consideration of their long-term use and alternative agentsJulie C Stevens
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, MA 02114, USA
J Clin Psychiatry 66:21-7. 2005..We also consider currently available alternatives to benzodiazepines and novel mechanisms of action that may prove fruitful in the development of future generations of anxiolytics...
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolamKarl Rickels
Department of Psychiatry, University of Pennsylvania, Philadelphia 19104 3309, USA
Arch Gen Psychiatry 62:1022-30. 2005..Pregabalin inhibits release of excess excitatory neurotransmitters, presumably by binding to the alpha2-delta subunit protein of widely distributed voltage-dependent calcium channels in the brain and spinal cord...
Khyâl attacks: a key idiom of distress among traumatized cambodia refugeesDevon E Hinton
Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital, 15 Parkman Street, WACC 812, Boston, MA 02114, USA
Cult Med Psychiatry 34:244-78. 2010....
Ataque de nervios: relationship to anxiety sensitivity and dissociation predispositionDevon E Hinton
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
Depress Anxiety 25:489-95. 2008..46) and the DES (beta=.29). The theoretical and clinical implications of the strong relationship of the ASI to ataque severity are discussed...
The role of anxiety sensitivity in sleep disturbance in panic disorderE A Hoge
Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114 2790, USA
J Anxiety Disord 25:536-8. 2011..Our data suggest that sleep disturbance, and in particular sleep latency, in PD may be partly due to high levels of AS, which can be targeted with cognitive-behavioral therapeutic strategies...
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disordersM W Otto
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Br J Psychiatry 189:20-5. 2006..The impact of anxiety disorders has not been well delineated in prospective studies of bipolar disorder...
Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replicationE H Uhlenhuth
Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque 87131, USA
J Clin Psychopharmacol 20:622-7. 2000..Implications of these results for concepts of pathogenesis, clinical practice, and therapeutic research regarding panic disorder are discussed...
How do clinicians respond to patients who miss appointments?J W Smoller
Department of Psychiatry, Massachusetts General Hospital, Boston 02114, USA
J Clin Psychiatry 59:330-8; quiz 339-40. 1998..quot; In an effort to determine how clinicians customarily handle missed appointments, we surveyed mental health clinicians and internists at 2 academic hospitals: a private psychiatric hospital and an urban general hospital...
An open-label study of levetiracetam for the treatment of social anxiety disorderNaomi M Simon
Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
J Clin Psychiatry 65:1219-22. 2004..02) scores. CONCLUSIONS: This pilot study supports the safety and potential efficacy of a novel agent, levetiracetam, for the treatment of social anxiety disorder. Larger controlled trials are warranted to confirm these results...
Orthostatic panic attacks among Vietnamese refugeesDevon E Hinton
Harvard Medical School, Massachusetts General Hospital, Department of Psychiatry, Boston 02114, USA
Transcult Psychiatry 44:515-44. 2007..To illustrate the mechanisms producing OP, we adduce the multiplex model of panic generation. Culturally appropriate care of Vietnamese refugees should include assessment and treatment of OP...
Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patientsJohn J Worthington
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Massachusetts, USA
Int Clin Psychopharmacol 20:9-11. 2005..Because this is a retrospective case review, further prospective studies are required to confirm these findings...
Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disordersMichael W Otto
Massachusetts General Hospital and Harvard Medical School, MA, United States
J Anxiety Disord 21:888-902. 2007..Given the links between PTSD symptoms and viewing habits, parental monitoring of media exposure may be important for younger children...
Anger, PTSD, and the nuclear family: a study of Cambodian refugeesDevon E Hinton
Massachusetts General Hospital, Harvard Medical School, Department of Psychiatry, Boston, USA
Soc Sci Med 69:1387-94. 2009....
Citalopram for social phobia: a clinical case seriesN M Simon
Anxiety Disorders Program, Massachusetts General Hospital, Boston 02114, USA
Prog Neuropsychopharmacol Biol Psychiatry 25:1469-74. 2001..This series of patients improved significantly on all measures. Results suggest that citalopram may be a safe and effective treatment for social anxiety disorder...
Nefazodone for social phobia: a clinical case seriesJ J Worthington
Anxiety Disorders Program, Massachusetts General Hospital, Boston, USA
Depress Anxiety 8:131-3. 1998..Results from this case series suggest that nefazodone may be an effective treatment for social phobia and that formal randomized trials are warranted...
Empirically supported treatments for panic disorder: costs, benefits, and stepped careM W Otto
Massachusetts General Hospital, Boston 02114, USA
J Consult Clin Psychol 68:556-63. 2000..Analysis of the "services" data indicated that CBT was at least equal to pharmacotherapy in terms of pretreatment severity and acute treatment outcome and that CBT is an especially cost-effective treatment option...
Gastrointestinal-focused panic attacks among Cambodian refugees: associated psychopathology, flashbacks, and catastrophic cognitionsDevon E Hinton
Massachusetts General Hospital, Harvard Medical School, Department of Psychiatry, 15 Parkman Street, WACC 812 Boston, USA
J Anxiety Disord 21:42-58. 2007..A mediational analysis indicated that SCL's effect on GIP severity was mediated by GIP-associated flashbacks and catastrophic cognitions...
Establishment of remission criteria for anxiety disordersAlicia C Doyle
Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA
J Clin Psychiatry 64:40-5. 2003....
Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluationMichael W Otto
Department of Psychology, Boston University, 648 Beacon Street, 5th Floor, Boston, MA 02215, USA
Behav Res Ther 48:720-7. 2010..These findings suggest that CBT provides specific efficacy for the successful discontinuation from BZs, even when controlling for therapist contact and relaxation training...
WCA recommendations for the long-term treatment of generalized anxiety disorderChrister Allgulander
Department of Psychiatry, Harvard University School of Medicine, Boston, Massachusetts, USA
CNS Spectr 8:53-61. 2003..Treatment gains after a 12-week course of CBT may be maintained for up to 1 year. Currently, no guidelines exist for the long-term treatment of GAD...
Brain GABA levels in patients with bipolar disorderRebecca E Kaufman
Massachusetts General Hospital Department of Psychiatry, Boston, MA 02114, United States
Prog Neuropsychopharmacol Biol Psychiatry 33:427-34. 2009..GENERAL METHODS: We used magnetic resonance spectroscopy (MRS) to examine whole brain and regional GABA, glutamate and glutamine in 13 patients with bipolar disorder compared to a matched group of 11 healthy controls...
Mechanisms of efficacy of CBT for Cambodian refugees with PTSD: improvement in emotion regulation and orthostatic blood pressure responseDevon E Hinton
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, WACC 812, Boston, MA, USA
CNS Neurosci Ther 15:255-63. 2009..It also suggests that vagal tone is involved in emotion regulation, and that both vagal tone and emotion regulation improve across treatment...
Olfactory-triggered panic attacks among Cambodian refugees attending a psychiatric clinicDevon E Hinton
Department of Psychiatry, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA
Gen Hosp Psychiatry 26:390-7. 2004....
Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regionsJ W Smoller
Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA
Am J Med Genet 105:195-206. 2001..05, P = 0.035). While these linkage results are merely suggestive, this study illustrates the potential advantages of using mouse gene-mapping results and exploring alternative phenotype definitions in linkage studies of anxiety disorder...
Additional findings on the association between anxiety sensitivity and hypochondriacal concerns: examination of patients with major depressionM W Otto
Cognitive Behavior Therapy Program, Massachusetts General Hospital, Boston 02114, USA
J Anxiety Disord 12:225-32. 1998..Findings are discussed in relation to the role of catastrophic interpretations of somatic symptoms in depression, panic disorder, and hypochondriasis...
Sleep paralysis among Cambodian refugees: association with PTSD diagnosis and severityDevon E Hinton
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
Depress Anxiety 22:47-51. 2005..SP seems to be a core aspect of the Cambodian refugee's response to trauma. When treating Cambodian refugees, and traumatized refugees in general, clinicians should assess for its presence...
Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health InitiativeJordan W Smoller
Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA
Arch Intern Med 163:2041-50. 2003..Panic attacks are known to be more common in women than in men, but the prevalence and correlates of panic in the postmenopausal period have not been well defined...
Long-term management of panic disorderAlicia Doyle
Center for Anxiety and Traumatic Stress Related Disorders, Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Mass, USA
J Clin Psychiatry 65:24-8. 2004..Further research is necessary to determine the long-term effectiveness of these multifaceted treatment strategies among patients suffering from refractory panic disorder...
Augmentation of exposure therapy with D-cycloserine for social anxiety disorderStefan G Hofmann
Department of Psychology and Center for Anxiety and Related Disorders, Boston University, Boston, MA 02215, USA
Arch Gen Psychiatry 63:298-304. 2006..Controlled effect sizes were in the medium to large range. CONCLUSION: The pilot data provide preliminary support for the use of short-term dosing of d-cycloserine as an adjunctive intervention to exposure therapy for SAD...
Orthostatically induced panic attacks among Vietnamese refugees: associated psychopathology, flashbacks, and catastrophic cognitionsDevon E Hinton
Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA
Depress Anxiety 23:113-5. 2006
Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatmentMarisa M Silveri
Brain Imaging Center, McLean Hospital, Department of Psychiatry, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA
Psychiatry Res 131:217-26. 2004..Taken together, these cross-sectional data suggest that the first month of MM treatment may be associated with altered cerebral bioenergetics and phospholipid metabolite levels...
Ropinirole for antidepressant-induced sexual dysfunctionJ J Worthington
Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA
Int Clin Psychopharmacol 17:307-10. 2002..The addition of ropinirole may represent a potentially useful treatment strategy for antidepressant-induced sexual dysfunction...
An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorderM W Otto
Massachusetts General Hospital, Boston, MA 02114, USA
Am J Psychiatry 158:1989-92. 2001..In this study the authors used an effect-size analysis to provide an initial comparison...
Nightmares among Cambodian refugees: the breaching of concentric ontological securityD E Hinton
Massachusetts General Hospital, Harvard Medical School, Boston, MA 02115, USA
Cult Med Psychiatry 33:219-65. 2009..quot; Cases are presented to illustrate these findings. The Discussion considers some treatment implications of the study...
Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational StudyJordan W Smoller
Department of Psychiatry, Massachusetts General Hospital, Simches Research Building, 185 Cambridge Street, Boston, MA 02114, USA
Arch Gen Psychiatry 64:1153-60. 2007..Previous studies have documented an association of depression and phobic anxiety with cardiovascular morbidity and mortality, but little is known about the cardiovascular sequelae of panic anxiety...
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapyNaomi M Simon
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, MA 02114, USA
J Clin Psychiatry 69:400-5. 2008..This study prospectively examines the relative efficacy of augmentation of continued prolonged exposure therapy (PE) with paroxetine CR versus placebo for individuals remaining symptomatic despite a course of PE...
Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trialNaomi M Simon
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Simches Research Building, 2nd Floor, 185 Cambridge St, Boston, MA 02114, USA
J Clin Psychiatry 70:1563-70. 2009..More data are needed to guide next-step interventions for panic disorder refractory to initial intervention...
An open-label trial of risperidone augmentation for refractory anxiety disordersNaomi M Simon
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Boston, Mass, USA
J Clin Psychiatry 67:381-5. 2006..There is a paucity of data to support "next-step" treatments for the many patients with anxiety disorders who remain symptomatic after initial pharmacotherapy...
A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorderKarleyton C Evans
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02129, USA
Depress Anxiety 25:496-505. 2008..However, extending earlier findings in healthy subjects, schematic faces appear more effective for probing amygdala responses to arousal-based (Angry versus Neutral) as opposed to valence-based (Angry versus Happy) contrasts...
Resilience: research evidence and conceptual considerations for posttraumatic stress disorderElizabeth A Hoge
Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Depress Anxiety 24:139-52. 2007....
Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorderNaomi M Simon
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston MA 02114, United States
J Affect Disord 97:91-9. 2007..Prior studies suggest an association between anxiety comorbidity and suicidal ideation and behaviors in bipolar disorder. However, the nature of this association remains unclear...
White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjectsIn Kyoon Lyoo
McLean Hospital Brain Imaging Center and Department of Psychiatry, Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA
Psychiatry Res 131:135-45. 2004..Also, there was a trend for lower WMH severity in substance-dependent women relative to the healthy comparison group, possibly due to estrogen's protective effect against cerebrovascular accidents...
Valproic acid for the treatment of social anxiety disorderGustavo Kinrys
Massachusetts General Hospital, Boston 02114, USA
Int Clin Psychopharmacol 18:169-72. 2003..The results from this open-label trial suggest the potential efficacy of valproic acid for the treatment of social anxiety disorder. Placebo-controlled trials are indicated to confirm these findings...
Predicting panic disorder among patients with chest pain: an analysis of the literatureJeff C Huffman
Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Psychosomatics 44:222-36. 2003..female sex, 4). younger age, and 5). a high level of self-reported anxiety. Further studies of these and other variables associated with panic disorder should aid in the detection of this disabling but treatable cause of chest pain...
Anxiety sensitivity in traumatized Cambodian refugees: a discriminant function and factor analytic investigationDevon E Hinton
Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
Behav Res Ther 43:1631-43. 2005..The item clustering within the factor solution of both the ASI and Augmented ASI illustrates the role of cultural syndromes in generating fear of mental and bodily events...
Quality of life in social anxiety disorder compared with panic disorder and the general populationNaomi M Simon
Anxiety Disorders Program, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
Psychiatr Serv 53:714-8. 2002..Quality of life in a treatment-seeking cohort of patients with social anxiety disorder was compared with that of patients with panic disorder who were matched for age, comorbid illnesses, and gender and with population-based norms...
Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot studyNaomi M Simon
Center for Anxiety and Traumatic Stress Related Disorders, Massachusetts General Hospital, WACC 815, Boston, MA 02114, USA
Psychosomatics 46:334-9. 2005..The data add to the literature suggesting a role for selective serotonin reuptake inhibitors in the treatment of dizziness and anxiety...
Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sampleJoseph Biederman
Pediatric Psychopharmacology Unit of the Child Psychiatry Service, Massachusetts General Hospital, Boston 02114, USA
Depress Anxiety 21:55-60. 2005....
Changes in anxiety sensitivity with pharmacotherapy for panic disorderNaomi M Simon
Anxiety Disorders Program, Massachusetts General Hospital and Harvard Medical School, WACC 812, 15 Parkman Street, Boston, MA 02114, USA
J Psychiatr Res 38:491-5. 2004..Implications of these findings are discussed relative to optimizing pharmacologic treatment of panic disorder...
A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorderKarleyton C Evans
Department of Psychiatry, Psychiatric Neuroscience Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA
Neuropsychopharmacology 34:390-8. 2009..Given the pharmacological profile of tiagabine, these findings suggest that its therapeutic effects in gSAD may be mediated by GABAergic modulation within the vmPFC...
Oxytocin levels in social anxiety disorderElizabeth A Hoge
Department of Economics, Claremont University, Claremont, CA, USA
CNS Neurosci Ther 14:165-70. 2008..These findings may suggest a possible role for oxytocin as a facilitator of social behavior, an effect which may not be fully utilized in individuals with severe social anxiety...
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BDNaomi M Simon
Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
J Clin Psychopharmacol 24:512-20. 2004..Our findings highlight the need for greater clinical guidance and treatment options for patients with bipolar disorder and comorbidity...
Open-label support for duloxetine for the treatment of panic disorderNaomi M Simon
Department of Psychiatry, Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA
CNS Neurosci Ther 15:19-23. 2009....
Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature reviewNaomi M Simon
Anxiety Disorders Program, Massachusetts General Hospital and Harvard Medical School, 15 Parkman Street, WAC 815, Boston, MA 02114, USA
J Affect Disord 69:209-17. 2002..The need for thyroid screening of patients presenting with panic disorder (PD), social phobia (SP) or generalized anxiety disorder (GAD) remains uncertain...
A comparison of emotional approach coping (EAC) between individuals with anxiety disorders and nonanxious controlsLuana Marques
Center for Anxiety and Traumatic Stress Disorders, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA
CNS Neurosci Ther 15:100-6. 2009..Overall, gender did not moderate the anxiety-EAC effect, but the results suggested that women utilize EAC to a greater degree than men. Clinical techniques designed to improve emotional coping may be beneficial to individuals with ADs...
Research Grants
- 3/3-Exposure D-Cycloserine Enhancement and Genetic Modulators in Panic DisorderMark Pollack; Fiscal Year: 2009....
- Improving Outcomes in Pharmacotherapy of Social PhobiaMark Pollack; Fiscal Year: 2009..It thus directly addresses a critical public health issue that adversely affects a substantial proportion of the population. ..
- 3/3-Exposure D-Cycloserine Enhancement and Genetic Modulators in Panic DisorderMark H Pollack; Fiscal Year: 2010....
- D-Cycloserine Enhancement of Exposure in Social PhobiaMark H Pollack; Fiscal Year: 2010..This study addresses an important public health issue by assessing an intervention that may lead to a more efficient and effective application of empirically based psychosocial interventions for the treatment of SAD. ..
- Improving Outcomes in Pharmacotherapy of Social PhobiaMark Pollack; Fiscal Year: 2007..It thus directly addresses a critical public health issue that adversely affects a substantial proportion of the population. ..
- MR SPECTROSCOPIC IMAGING DURING METHADONE MAINTENANCEMark Pollack; Fiscal Year: 2002....
- Impact of Trauma of Terroist Attack on Bipolar PatientsMark Pollack; Fiscal Year: 2003..abstract_text> ..
- D-Cycloserine Enhancement of Exposure in Social PhobiaMark H Pollack; Fiscal Year: 2010..This study addresses an important public health issue by assessing an intervention that may lead to a more efficient and effective application of empirically based psychosocial interventions for the treatment of SAD. ..
